My Lung Cancer has recurred. How does this change my treatment choices, and are new targeted therapies using...

Lung CancerOctober 15, 2025Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case. No signup, answered right here.

or Upload your records for answers about your actual case

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

Grounded in NCCN Guidelines for Patients: Non-Small Cell Lung Cancer — the same guidelines oncologists use.
Built by OpenCancer’s team of physician-scientists and cancer survivors.
Last updated October 15, 2025. Informational only — not a substitute for your oncology team.

Question asked:

My Lung Cancer has recurred. How does this change my treatment choices, and are new targeted therapies using biomarkers (EGFR, ALK, PD-L1) available?

According to the NCCN Guidelines for Non-Small Cell Lung Cancer (2023), treatment choices for recurrent lung cancer depend on several factors:

Biomarker Testing: The NCCN Guidelines strongly recommend comprehensive biomarker testing for all recurrent lung cancers, specifically for:

EGFR mutations
ALK rearrangements
PD-L1 expression
ROS1, BRAF, NTRK, MET, RET, and KRAS mutations

Treatment Options: The American Society of Clinical Oncology (ASCO) guidelines outline several approaches based on biomarker results:

If you have specific mutations (like EGFR or ALK), targeted therapies may be your best option
High PD-L1 expression might indicate immunotherapy as an effective choice
Combinations of immunotherapy and chemotherapy may be recommended in certain cases

The National Cancer Institute (NCI) highlights that newer targeted therapies have shown improved outcomes for recurrent lung cancer, with several recent FDA approvals including:

Multiple generations of EGFR inhibitors
New ALK inhibitors
Various immunotherapy options

Important recommendations:

Get comprehensive biomarker testing before starting new treatment
Discuss your specific biomarker results with your oncologist
Consider clinical trial options, which may provide access to newest treatments

Please remember that treatment decisions should be individualized and made in consultation with your healthcare team, who can review your specific case, including your previous treatments and current health status.

Would you like more specific information about any of these treatment approaches or biomarker testing?

Ask Navis about your case

That answer is general. Ask about your specific situation. No signup, answered right here.

or Upload your records for answers about your actual case

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →